Associations between attention-deficit hyperactivity disorder genetic liability and ICD-10 medical conditions in adults: utilizing electronic health records in a Phenome-Wide Association StudyShow others and affiliations
2024 (English)In: Psychological Medicine, ISSN 0033-2917, E-ISSN 1469-8978, Vol. 54, no 10, p. 2468-2481Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Attention-deficit hyperactivity disorder (ADHD) is often comorbid with other medical conditions in adult patients. However, ADHD is extremely underdiagnosed in adults and little is known about the medical comorbidities in undiagnosed adult individuals with high ADHD liability. In this study we investigated associations between ADHD genetic liability and electronic health record (EHR)-based ICD-10 diagnoses across all diagnostic categories, in individuals without ADHD diagnosis history.
METHODS: We used data from the Estonian Biobank cohort (N = 111 261) and generated polygenic risk scores (PRS) for ADHD (PRSADHD) based on the ADHD genome-wide association study. We performed a phenome-wide association study (PheWAS) to test for associations between standardized PRSADHD and 1515 EHR-based ICD-10 diagnoses in the full and sex-stratified sample. We compared the observed significant ICD-10 associations to associations with (1) ADHD diagnosis and (2) questionnaire-based high ADHD risk analyses.
RESULTS: After Bonferroni correction (p = 3.3 × 10-5) we identified 80 medical conditions associated with PRSADHD. The strongest evidence was seen with chronic obstructive pulmonary disease (OR 1.15, CI 1.11-1.18), obesity (OR 1.13, CI 1.11-1.15), and type 2 diabetes (OR 1.11, CI 1.09-1.14). Sex-stratified analysis generally showed similar associations in males and females. Out of all identified associations, 40% and 78% were also observed using ADHD diagnosis or questionnaire-based ADHD, respectively, as the predictor.
CONCLUSIONS: Overall our findings indicate that ADHD genetic liability is associated with an increased risk of a substantial number of medical conditions in undiagnosed individuals. These results highlight the need for timely detection and improved management of ADHD symptoms in adults.
Place, publisher, year, edition, pages
Cambridge University Press, 2024. Vol. 54, no 10, p. 2468-2481
Keywords [en]
Attention-deficit/hyperactivity disorder, comorbidity, phenome-wide association study, physical disease, polygenic risk scores, somatic disease
National Category
Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-112924DOI: 10.1017/S0033291724000606ISI: 001195283700001PubMedID: 38563284Scopus ID: 2-s2.0-85189302692OAI: oai:DiVA.org:oru-112924DiVA, id: diva2:1849947
Funder
EU, Horizon 2020, 692145; 965381Swedish Research Council, 2018-02599The Swedish Brain Foundation, FO2021-0115
Note
This research in the Estonian Biobank was supported by the European Union through the European Regional Development Fund (Project No. 2014-2020.4.01.15-0012 GENTRANSMED and 2014-2020.4.01.16-0125), and the Estonian Research Council's grant No. PSG615. This study was also funded by EU H2020 grant 692145, Estonian Research Council Grant IUT20-60, IUT24-6. This research is also part of the TIMESPAN project that has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 965381. Henrik Larsson acknowledges financial support from the Swedish Research Council (2018-02599) and the Swedish Brain Foundation (FO2021-0115). Isabell Brikell acknowledges financial support from the Swedish Brain Foundation.
2024-04-092024-04-092024-11-19Bibliographically approved